top of page
School of Clinical Oncology Final (1).pn
CME 17102020 .png

Lung Cancer is the second and third most common cancer in males and females respectively, and the leading cause of cancer death in Singapore. Unfortunately, traditional treatment approaches with open surgery and conventional chemotherapy/radiation are often morbid, resulting in poor quality of life.


The 21st century has heralded an era of Precision Oncology, where scientific advances have provided a new armamentarium of treatment options for lung oncologists and surgeons. From molecular diagnostics, to minimally invasive surgery, to stereotactic ablative radiosurgery, and targeted/ immuno-therapies, these latest options have provided new hope in our fight against lung cancer.


Join us for this educational, multi-disciplinary webinar where we welcome our panel of lung cancer experts to summarise the key updates in their respective specialties. Opinion polls and a dedicated Q&A session were included to ensure maximal participation and interaction!

bottom of page